CSIMarket Company Name, Ticker, Competitors, else..
 
Sorrento Therapeutics Inc   (SRNEQ)
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 551
 Employees 30
 Revenues (TTM) (Millions $) 64
 Net Income (TTM) (Millions $) -354
 Cash Flow (TTM) (Millions $) 11
 Capital Exp. (TTM) (Millions $) 6

Business Description


Sorrento Therapeutics Inc is a biopharmaceutical company that develops and commercializes innovative immunotherapies for cancer and autoimmune diseases. The company focuses on the discovery and development of antibody-based therapies, with a particular emphasis on the development of next-generation antibody-drug conjugates (ADCs). Sorrento's technology platforms include proprietary G-MAB antibody libraries, as well as CAR-T cell therapy and small molecule platforms. The company aims to provide targeted and personalized treatment options for patients by harnessing the power of the immune system.


   Company Address: 4955 Directors Place San Diego 92121 CA
   Company Phone Number: 203-4100   Stock Exchange / Ticker: SRNEQ


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
AMGN        1.3% 
EXEL        7.84% 
GILD        3.43% 
MRNA        5.82% 
NVAX        12.04% 
SGEN        4.77% 
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 0.3
Working Capital Ratio 0.5
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -1.16 $
Revenues (TTM) 0.12 $
Cash Flow (TTM) 0.02 $
Cash 0.15 $
Book Value -
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) 2,142,333
Net Income per Employee (TTM) -11,792,900
Receivable Turnover Ratio (TTM) 2.38
Inventory Turnover Ratio (TTM) 1.45
Asset Turnover Ratio (TTM) 0.15

Profitability Ratios Current
Gross Margin (MRQ) 56.31 %
Operating Margin (MRQ) -514.03 %
Net Margin (MRQ) -722.37 %
Net Cash Flow Margin (MRQ) 219.73 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.